[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$figDiBq0SJos43NsPIVa8GGElp1tvLg_Z36KGn1ytfGk":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":55,"rows":62},"Spaulding Rehabilitation Hospital",[4],111,false,32,1,4251,5,99,[14,17,19,22,25,27,30,32],{"name":15,"count":16},"Spinal Cord Injuries",17,{"name":18,"count":16},"Stroke",{"name":20,"count":21},"Chronic Pain",12,{"name":23,"count":24},"Spinal Cord Injury",7,{"name":26,"count":11},"Traumatic Brain Injury",{"name":28,"count":29},"Cerebral Palsy",4,{"name":31,"count":29},"Fibromyalgia",{"name":33,"count":29},"Healthy",[35,40,45,50],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT05626894","Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors","2026-06-30","StrokeWear Motor and Behavioral Intervention",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT04458324","Hybrid Functional Electrical Stimulation Exercise to Prevent Cardiopulmonary Declines in High-level Spinal Cord Injury","2026-07-31","Buspirone Hydrochloride",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT06066853","MDMA-assisted Therapy for Fibromyalgia","2026-12","MDMA",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT07588932","Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors","2027-10-31","Telmisartan, Metformin, Cilostazol",[56,57,58,59,60,61],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[63,87,105,128,148,170,197,215,241,266,291,315,351,378],{"intervention":44,"totalTrials":9,"cells":64},{"EARLY_PHASE1":65,"PHASE1":68,"PHASE2":70,"PHASE3":81,"PHASE4":83,"NA":85},{"trials":66,"activeCount":67},[],0,{"trials":69,"activeCount":67},[],{"trials":71,"activeCount":9,"soonestReadout":43},[72],{"nctId":41,"briefTitle":42,"status":73,"phases":74,"primaryCompletion":43,"completion":75,"start":76,"enrollment":77,"conditions":78,"interventions":79},"ACTIVE_NOT_RECRUITING",[58],"2027-07-31","2020-12-22",70,[15],[44,80],"Buspirone placebo",{"trials":82,"activeCount":67},[],{"trials":84,"activeCount":67},[],{"trials":86,"activeCount":67},[],{"intervention":80,"totalTrials":9,"cells":88},{"EARLY_PHASE1":89,"PHASE1":91,"PHASE2":93,"PHASE3":99,"PHASE4":101,"NA":103},{"trials":90,"activeCount":67},[],{"trials":92,"activeCount":67},[],{"trials":94,"activeCount":9,"soonestReadout":43},[95],{"nctId":41,"briefTitle":42,"status":73,"phases":96,"primaryCompletion":43,"completion":75,"start":76,"enrollment":77,"conditions":97,"interventions":98},[58],[15],[44,80],{"trials":100,"activeCount":67},[],{"trials":102,"activeCount":67},[],{"trials":104,"activeCount":67},[],{"intervention":39,"totalTrials":9,"cells":106},{"EARLY_PHASE1":107,"PHASE1":109,"PHASE2":111,"PHASE3":122,"PHASE4":124,"NA":126},{"trials":108,"activeCount":67},[],{"trials":110,"activeCount":67},[],{"trials":112,"activeCount":9,"soonestReadout":38},[113],{"nctId":36,"briefTitle":37,"status":114,"phases":115,"primaryCompletion":38,"completion":116,"start":117,"enrollment":8,"conditions":118,"interventions":121},"RECRUITING",[58],"2026-09-30","2025-03-20",[18,119,120],"Stroke Sequelae","Hemiparesis;Poststroke\u002FCVA",[39],{"trials":123,"activeCount":67},[],{"trials":125,"activeCount":67},[],{"trials":127,"activeCount":67},[],{"intervention":49,"totalTrials":9,"cells":129},{"EARLY_PHASE1":130,"PHASE1":138,"PHASE2":140,"PHASE3":142,"PHASE4":144,"NA":146},{"trials":131,"activeCount":9,"soonestReadout":48},[132],{"nctId":46,"briefTitle":47,"status":114,"phases":133,"primaryCompletion":48,"completion":48,"start":134,"enrollment":135,"conditions":136,"interventions":137},[56],"2026-04-01",20,[31],[49],{"trials":139,"activeCount":67},[],{"trials":141,"activeCount":67},[],{"trials":143,"activeCount":67},[],{"trials":145,"activeCount":67},[],{"trials":147,"activeCount":67},[],{"intervention":54,"totalTrials":9,"cells":149},{"EARLY_PHASE1":150,"PHASE1":160,"PHASE2":162,"PHASE3":164,"PHASE4":166,"NA":168},{"trials":151,"activeCount":9,"soonestReadout":53},[152],{"nctId":51,"briefTitle":52,"status":153,"phases":154,"primaryCompletion":53,"completion":155,"start":156,"enrollment":157,"conditions":158,"interventions":159},"NOT_YET_RECRUITING",[56],"2028-12-31","2026-05-18",50,[18],[54],{"trials":161,"activeCount":67},[],{"trials":163,"activeCount":67},[],{"trials":165,"activeCount":67},[],{"trials":167,"activeCount":67},[],{"trials":169,"activeCount":67},[],{"intervention":171,"totalTrials":9,"cells":172},"Prolotherapy",{"EARLY_PHASE1":173,"PHASE1":175,"PHASE2":177,"PHASE3":179,"PHASE4":193,"NA":195},{"trials":174,"activeCount":67},[],{"trials":176,"activeCount":67},[],{"trials":178,"activeCount":67},[],{"trials":180,"activeCount":67},[181],{"nctId":182,"briefTitle":183,"status":184,"phases":185,"completion":186,"start":187,"enrollment":188,"conditions":189,"interventions":191},"NCT00160303","Efficacy Study of Prolotherapy vs Corticosteroid for Tennis Elbow","COMPLETED",[59],"2006-12","2005-01",56,[190],"Lateral Epicondylitis",[171,192],"Local Corticosteroid Therapy",{"trials":194,"activeCount":67},[],{"trials":196,"activeCount":67},[],{"intervention":192,"totalTrials":9,"cells":198},{"EARLY_PHASE1":199,"PHASE1":201,"PHASE2":203,"PHASE3":205,"PHASE4":211,"NA":213},{"trials":200,"activeCount":67},[],{"trials":202,"activeCount":67},[],{"trials":204,"activeCount":67},[],{"trials":206,"activeCount":67},[207],{"nctId":182,"briefTitle":183,"status":184,"phases":208,"completion":186,"start":187,"enrollment":188,"conditions":209,"interventions":210},[59],[190],[171,192],{"trials":212,"activeCount":67},[],{"trials":214,"activeCount":67},[],{"intervention":216,"totalTrials":9,"cells":217},"Oxycodone",{"EARLY_PHASE1":218,"PHASE1":220,"PHASE2":222,"PHASE3":235,"PHASE4":237,"NA":239},{"trials":219,"activeCount":67},[],{"trials":221,"activeCount":67},[],{"trials":223,"activeCount":67},[224],{"nctId":225,"briefTitle":226,"status":184,"phases":227,"primaryCompletion":228,"completion":228,"start":229,"enrollment":230,"conditions":231,"interventions":234},"NCT03906721","Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Patients With Spinal Cord Injury, Polytrauma and Burn Injury",[58],"2021-11-01","2019-02-20",30,[15,232,233],"Polytrauma","Burn Injury",[216],{"trials":236,"activeCount":67},[],{"trials":238,"activeCount":67},[],{"trials":240,"activeCount":67},[],{"intervention":242,"totalTrials":9,"cells":243},"Caffeine",{"EARLY_PHASE1":244,"PHASE1":246,"PHASE2":248,"PHASE3":260,"PHASE4":262,"NA":264},{"trials":245,"activeCount":67},[],{"trials":247,"activeCount":67},[],{"trials":249,"activeCount":67},[250],{"nctId":251,"briefTitle":252,"status":184,"phases":253,"primaryCompletion":254,"completion":255,"start":256,"enrollment":257,"conditions":258,"interventions":259},"NCT02323698","Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury",[57,58],"2021-03-19","2022-02-19","2019-01-01",36,[15],[242],{"trials":261,"activeCount":67},[],{"trials":263,"activeCount":67},[],{"trials":265,"activeCount":67},[],{"intervention":267,"totalTrials":9,"cells":268},"Huperzine A",{"EARLY_PHASE1":269,"PHASE1":271,"PHASE2":273,"PHASE3":285,"PHASE4":287,"NA":289},{"trials":270,"activeCount":67},[],{"trials":272,"activeCount":67},[],{"trials":274,"activeCount":67},[275],{"nctId":276,"briefTitle":277,"status":278,"phases":279,"primaryCompletion":280,"completion":280,"start":281,"enrollment":282,"conditions":283,"interventions":284},"NCT01676311","Effects of Huperzine A in Treatment of Moderate to Severe TBI","TERMINATED",[58],"2018-08","2013-12",14,[26],[267],{"trials":286,"activeCount":67},[],{"trials":288,"activeCount":67},[],{"trials":290,"activeCount":67},[],{"intervention":292,"totalTrials":9,"cells":293},"Buspirone",{"EARLY_PHASE1":294,"PHASE1":296,"PHASE2":298,"PHASE3":309,"PHASE4":311,"NA":313},{"trials":295,"activeCount":67},[],{"trials":297,"activeCount":67},[],{"trials":299,"activeCount":67},[300],{"nctId":301,"briefTitle":302,"status":184,"phases":303,"primaryCompletion":304,"completion":304,"start":305,"enrollment":306,"conditions":307,"interventions":308},"NCT05041322","Improving Ventilatory Capacity in Those With Chronic High Level SCI",[58],"2024-11-01","2020-11-29",13,[15],[292],{"trials":310,"activeCount":67},[],{"trials":312,"activeCount":67},[],{"trials":314,"activeCount":67},[],{"intervention":316,"totalTrials":317,"cells":318},"fluoxetine",2,{"EARLY_PHASE1":319,"PHASE1":321,"PHASE2":323,"PHASE3":336,"PHASE4":338,"NA":340},{"trials":320,"activeCount":67},[],{"trials":322,"activeCount":67},[],{"trials":324,"activeCount":67},[325],{"nctId":326,"briefTitle":327,"status":184,"phases":328,"primaryCompletion":329,"completion":329,"start":330,"enrollment":331,"conditions":332,"interventions":334},"NCT02208466","Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients",[58],"2019-06-25","2014-09",44,[18,333],"Motor Function",[335],"Fluoxetine",{"trials":337,"activeCount":67},[],{"trials":339,"activeCount":67},[],{"trials":341,"activeCount":67},[342],{"nctId":343,"briefTitle":344,"status":345,"phases":346,"primaryCompletion":347,"completion":347,"start":348,"enrollment":67,"conditions":349,"interventions":350},"NCT01674868","Fluoxetine for Motor, Aphasia, and Neglect Recovery After Ischemic Stroke","WITHDRAWN",[61],"2015-12","2013-04",[18],[316],{"intervention":352,"totalTrials":9,"cells":353},"Audiovisual Guided Relaxation",{"EARLY_PHASE1":354,"PHASE1":356,"PHASE2":358,"PHASE3":360,"PHASE4":362,"NA":364},{"trials":355,"activeCount":67},[],{"trials":357,"activeCount":67},[],{"trials":359,"activeCount":67},[],{"trials":361,"activeCount":67},[],{"trials":363,"activeCount":67},[],{"trials":365,"activeCount":67},[366],{"nctId":367,"briefTitle":368,"status":184,"phases":369,"primaryCompletion":370,"completion":371,"start":372,"enrollment":373,"conditions":374,"interventions":376},"NCT03819907","The Use of Virtual Reality for Lumbar Pain Management in an Outpatient Spine Clinic",[61],"2019-07-09","2019-09-01","2019-04-08",45,[375],"Chronic Low Back Pain",[352,377],"Virtual Reality Guided Relaxation",{"intervention":377,"totalTrials":9,"cells":379},{"EARLY_PHASE1":380,"PHASE1":382,"PHASE2":384,"PHASE3":386,"PHASE4":388,"NA":390},{"trials":381,"activeCount":67},[],{"trials":383,"activeCount":67},[],{"trials":385,"activeCount":67},[],{"trials":387,"activeCount":67},[],{"trials":389,"activeCount":67},[],{"trials":391,"activeCount":67},[392],{"nctId":367,"briefTitle":368,"status":184,"phases":393,"primaryCompletion":370,"completion":371,"start":372,"enrollment":373,"conditions":394,"interventions":395},[61],[375],[352,377]]